Treace Medical Concepts (TMCI) Operating Expenses (2020 - 2026)
Treace Medical Concepts filings provide 6 years of Operating Expenses readings, the most recent being $56.3 million for Q4 2025.
- On a quarterly basis, Operating Expenses rose 1.15% to $56.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $223.9 million, a 0.02% change, with the full-year FY2025 number at $223.9 million, changed 0.02% from a year prior.
- Operating Expenses hit $56.3 million in Q4 2025 for Treace Medical Concepts, up from $55.4 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $59.9 million in Q1 2024 to a low of $16.8 million in Q1 2021.
- Median Operating Expenses over the past 5 years was $49.3 million (2023), compared with a mean of $44.8 million.
- Biggest five-year swings in Operating Expenses: soared 189.47% in 2021 and later fell 4.13% in 2025.
- Treace Medical Concepts' Operating Expenses stood at $33.7 million in 2021, then surged by 31.42% to $44.2 million in 2022, then skyrocketed by 30.01% to $57.5 million in 2023, then decreased by 3.21% to $55.7 million in 2024, then increased by 1.15% to $56.3 million in 2025.
- The last three reported values for Operating Expenses were $56.3 million (Q4 2025), $55.4 million (Q3 2025), and $54.7 million (Q2 2025) per Business Quant data.